The cannabis industry is growing like a weed. Since 2016, US revenue from cannabis has almost doubled.
In a very real and practical way, using one testing method can result in a different legal outcome than a using a different method.
“The evolving regulatory status of CBD”, a paper I co-wrote with Dr. Jamie Corroon, was published this week on the popular Project CBD website.
I enjoyed sharing a panel to discuss hemp legal issues with my friends and fellow attorneys at the Southern US Hemp Conference and Expo this week in Myrtle Beach, South Carolina.
Research suggests that some cannabinoids may, in fact, increase focus, suppress appetite and keep users awake.
One thing that appears to have gone unnoticed in all of the front page articles is the fact that Canada is not the largest jurisdiction in the world in which recreational (adult use) marijuana is lawful.
To say that all CBD is unlawful because it is a derivative of Cannabis is nonsensical; there are lawful and unlawful types of Cannabis.
The “Regulatory Status of Cannabidiol in the United States: A Perspective”, an article I co-wrote with Dr. Jamie Corroon, was published this week in Cannabis and Cannabinoid Research, a peer reviewed journal.
Congress has not yet enacted the 2018 Farm Bill. It is likely to pass within the next 8 weeks or so. However, what is the current legal status of industrial hemp now that the 2014 Farm Act has expired?
Canada is clearly leading the way on global cannabis reform; the question remains will the United States follow suit quickly enough to capitalize on this nascent market before Canada asserts its dominance as a global provider of quality hemp and marijuana products?